Related Experiment Video

Updated: Aug 14, 2026

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
09:02

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei

Published on: February 17, 2014

[Multifactorial experiment on the combined effect of rifampicin and microbial polysaccharide in experimental plague

A V Nikitin, L N Makarovskaia, I P Fomina

    Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]
    |May 1, 1991
    PubMed

    Insights

    This study found that combining rifampicin with a microbial polysaccharide creates a synergistic effect against experimental plague. This combination therapy offers an optimized approach to chemo-immunotherapy for plague infection.

    Area of Science:

    • Microbiology
    • Immunology
    • Pharmacology

    Context:

    • Experimental plague infection models are crucial for evaluating antimicrobial and immunomodulatory treatments.
    • Rifampicin is a key antibiotic used in plague treatment.
    • Microbial polysaccharides can act as immunomodulators, potentially enhancing treatment efficacy.

    Purpose:

    • To investigate the combined therapeutic effect of rifampicin and a microbial polysaccharide in experimental plague.
    • To determine if the combination exhibits synergistic activity compared to monotherapy.
    • To develop predictive models for optimizing the combined chemo-immunotherapy dosage.

    Summary:

    • Multifactorial analysis revealed a synergistic effect between rifampicin and a microbial polysaccharide in combating experimental plague.
    • Polynomial statistical models of the second order were developed based on the study's findings.
    • Nomograms were plotted to visualize and optimize the combined chemo- and immunotherapy strategy.

    Impact:

    • The study provides a data-driven approach to optimize plague treatment regimens.
    • Findings suggest a potentially more effective therapeutic strategy by combining antibiotics with immunomodulators.
    • The developed models and nomograms can guide clinical decisions for combined plague therapy.

    More Related Videos

    System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis09:57

    System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

    Published on: April 5, 2017

    A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis10:29

    A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

    Published on: March 24, 2017

    Related Concept Videos

    Plague01:24

    Plague

    Plague is a highly virulent zoonotic disease caused by Yersinia pestis, a Gram-negative, facultatively anaerobic coccobacillus. This pathogen primarily circulates among rodent populations and is transmitted to humans through the bite of infected fleas. Additional transmission routes include direct contact with infected animal tissue or inhalation of respiratory droplets from individuals with pneumonic plague. These multiple transmission pathways highlight the bacterium’s potential for rapid...